Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More

Lupin Receives Tentative FDA Approvals for Generic Nuvigil Tablets and Generic Oracea Capsules

Posted On: 2013-08-13 03:17:43

MSD, one of the world's leading players in 23-valent Pneumococcal Polysaccharide Vaccines category and Lupin Limited have formed an India-specific strategic partnership. Within the scope of partnership, Lupin will have a non-exclusive license to market, promote and distribute 23-valent Pneumococcal Polysaccharide Vaccine under a different brand name in India.

Pneumococcal disease is an infection caused by bacteria named Streptococcus pneumoniae and it results in variety of invasive and non-invasive pneumococcal diseases with pneumonia being the most common presentation in adults. Pneumococcal disease kills more patients worldwide than any other vaccine preventable diseases. Worldwide 1.6 million people die of pneumococcal disease every year which translates to 3 people dying every minute. Adults with co morbid conditions like chronic lung disease (COPD etc.), diabetes, chronic heart diseases, chronic liver diseases, immune compromised diseases as well as adults more than 65 years of age are at increased risk for pneumococcal diseases than healthy adults.

A recent study from India showed that the case fatality rate due to invasive pneumococcal disease observed in elderly is 26.4% which is much higher than that in children and highlights the need for preventive interventions in adults1

Identifying this significant risk, this partnership is built on a patient centric model, which will help improve vaccination rate for pneumococcal disease, in particular to high risk population group to help reduce incidence and mortality in adults.

Pneumococcal polysaccharide vaccine (PPV)

- Pneumococcal polysaccharide vaccine (PPV) addresses the need of prevention of pneumococcal disease in India with its proven efficacy and broader coverage.

- PPV23 provides broader coverage and has proven efficacy for prevention of pneumococcal diseases which help addresses the need of prevention of pneumococcal disease in India

- Based on the clinical experience since last 3 decades, PPV23 has good safety profile

- Recent India focused study showed that more than 80% of invasive serotype groups of Streptococcus pneumoniae causing disease in the elderly in India are included in the formulation of PPV 23 which makes this vaccine relevant from India perspective

- PPV23 is recommended worldwide for prevention of pneumococcal diseases in adults by leading medical societies like Advisory committee on Immunization Practices, American Diabetes Association, American Thoracic society, Geriatric society of India etc.

Shares of Lupin Ltd was last trading in BSE at Rs.839.60, up by Rs.20.40 or 2.49%. The stock hit an intraday high of Rs.847.55 and low of Rs.817.60.

The total traded quantity was 0.73 lakhs compared to 2 week average of 1.45 lakhs.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

V-Mart Retail Ltd opens new fashion store in Uttarakhand
Divi's Laboratories Ltd receives EIR from US FDA for Unit 2 at Vizag
L&T Construction to build Mumbai Trans Harbour Link Order valued at Rs.8,650 Crore
Videocon Industries Ltd calls for Board Meeting on Nov 24, 2017
USFDA completes inspection of SMS Pharmaceuticals Limited's Unit 2 at Bachupally
Strides Shasun divests India brand business to Eris Lifesciences
Eris Lifesciences Ltd Q2 PAT climbs to Rs. 93.14 crore
Arrow Greentech Ltd Q2 net profit slides to Rs. 4.92 crore
WEP Solutions Ltd Q2 net profit higher at Rs. 0.35 crore
Kamat Hotels India Ltd Q2 net profit jumps to Rs. 18.27 crore
James Warren Tea Ltd Q2 PAT falls to Rs. 12.91 crore
Pudumjee Paper Products Ltd Q2 PAT at Rs. 3.79 crore
Savera Industries Ltd Q2 net profit jumps to Rs. 3.11 crore
CRISIL A1+ rating assigned to Rs. 2000 crore CP Programme of Edelweiss Financial Services Ltd
Siyaram Silk Mills Ltd calls for Board Meeting on Nov 27, 2017
Shri Krishna Prasadam Ltd announces resignation of Directors
Palred Technologies Ltd calls for Board Meeting on Nov 25, 2017
Speciality Restaurants Ltd opens Machaan franchise restaurant at Ranchi
Yash Papers Ltd to announce Q2 results on Dec 1, 2017
Anuh Pharma Ltd to consider 2nd quarter results on Dec 7, 2017
ICRA A1+ rating assigned to Rs. 2000 crore CP Programme of Edelweiss Financial Services Ltd
Swagruha Infrastructure Ltd's MD resigns
Ground breaking for Cochin Shipyard's Global ship repair hub on Nov 17
Mayur Uniquoters Ltd Board declares Second Interim Dividend & approves Buyback of Equity Shares
ITI Limited calls for Board Meeting on Dec 14, 2017
Prataap Snacks Ltd arm launches Yum-Pie snacks
Virinchi Hospitals receives NABH accreditation
Spenta International Ltd Q2 net profit jumps to Rs. 1.19 crore
Karma Energy Ltd Q2 net profit lower at Rs. 1.71 crore
Mayur Uniquoters Ltd Q2 PAT rises to Rs. 22.51 crore
Indian Toners & Developers Limited Board to consider Dividend on Nov 27, 2017
Kiri Industries Ltd calls for Board Meeting on Nov 27, 2017
SPIC Calls for Board Meeting on Dec 4, 2017
Concord Drugs Ltd announces resignation of company secretary
Sunshield Chemicals Ltd receives order worth Rs. 28 crores
Kalyani Forge Ltd Q2 net profit slides to Rs. 1.26 crore
KG Denim Ltd Q2 loss at Rs. 0.47 crore
Reliance General Insurance enters into multi year Bancassurance partnership with YES Bank
Titan Securities Ltd announces resignation of Mr. Rakesh Kumar Gupta
Salzer Electronics Ltd reports Q2 net profit of Rs. 5.81 crore
Hindustan Hardy Spicer Ltd Q2 loss at Rs. 0.34 crore
Tube Investments of India Ltd appoints Mr. Ramesh K B Menon as additional director
Titan Securities Ltd announces resignation of Ms.Aditi Jha
NRB Bearings Ltd appoints COO
Atishay Ltd Ltd calls for Board Meeting on Nov 27, 2017
Radio City Introduces the Next Generation of FM Entertainment - Video City, India's First Video FM
Seamec Reverse Merges Group Company
Bigbloc Construction announces Q2 FY17-18 results
Confidence Petroleum India Ltd calls for Board Meeting on Nov 25, 2017
Sadbhav Infrastructure Project Ltd declares interim dividend of Rs. 0.20


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017